nnpNeurology, Neuropsychiatry, PsychosomaticsНеврология, нейропсихиатрия, психосоматика2074-27112310-1342"IMA-Press", LLC10.14412/2074-2711-2019-4-160-165nnp-1228Research ArticleCLINICAL OBSERVATIONSКЛИНИЧЕСКИЕ НАБЛЮДЕНИЯDiabetic cervicobrachial radiculoplexopathyДиабетическая шейно-плечевая радикулоплексопатияАхмеджановаЛ. Т.AkhmedzhanovaL. T.

 119021, Москва, ул. Россолимо, 11, стр. 1

11, Rossolimo St., Build. 1, Moscow 119021

luiziana78@mail.ruИсайкинА. И.IsaikinA. I.

119021, Москва, ул. Россолимо, 11, стр. 1

11, Rossolimo St., Build. 1, Moscow 119021

ЧерненкоО. А.ChernenkoO. A.

119021, Москва, ул. Россолимо, 11, стр. 1

11, Rossolimo St., Build. 1, Moscow 119021

ШорЮ. М.ShorYu. M.

119021, Москва, ул. Россолимо, 11, стр. 1

11, Rossolimo St., Build. 1, Moscow 119021

МеркуловаД. М.MerkulovaD. M.

119021, Москва, ул. Россолимо, 11, стр. 1;

129128, Москва, ул. Будайская, 2

11, Rossolimo St., Build. 1, Moscow 119021;

2, Budaiskaya St., Moscow 129128

КачановскийМ. С.KachanovskyM. S.

119021, Москва, ул. Россолимо, 11, стр. 1

11, Rossolimo St., Build. 1, Moscow 119021

ЩегловаН. С.ShcheglovaN. S.

119021, Москва, ул. Россолимо, 11, стр. 1

11, Rossolimo St., Build. 1, Moscow 119021

ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова (Сеченовский университет)» Минздрава РоссииРоссияI.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of RussiaRussian FederationФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова (Сеченовский университет)» Минздрава России; Неврологический центр им. Б.М. Гехта ОАО «РЖД»РоссияI.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia; B.M. Gekht Neurology Center, OAO “RZhD”Russian Federation201908122019114160165Copyright © Akhmedzhanova L.T., Isaikin A.I., Chernenko O.A., Shor Y.M., Merkulova D.M., Kachanovsky M.S., Shcheglova N.S., 20192019Ахмеджанова Л.Т., Исайкин А.И., Черненко О.А., Шор Ю.М., Меркулова Д.М., Качановский М.С., Щеглова Н.С.Akhmedzhanova L.T., Isaikin A.I., Chernenko O.A., Shor Y.M., Merkulova D.M., Kachanovsky M.S., Shcheglova N.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://nnp.ima-press.net/nnp/article/view/1228

Peripheral nervous system (PNS) damage is one of the most common complications of diabetes mellitus. There may be different PNS damage types that differ in clinical symptoms and pathogenesis. A clinical case of diabetic cervicobrachial radiculoplexopathy is presented for the first time in Russia. The paper discusses the clinical features of this type versus diabetic lumbosacral radiculoplexopathy, instrumental diagnosis of diabetic radiculoplexopathies, pathogenetic mechanisms of the disease, and treatment approaches. It shows the efficacy of alpha-lipoic acid supplementation in a patient with diabetic radiculoplexopathy.

Поражение периферической нервной системы (ПНС) является одним из наиболее частых осложнений сахарного диабета. Возможны различные варианты поражения ПНС, которые отличаются по клинической симптоматике и патогенезу. Впервые в России представлено клиническое наблюдение диабетической шейно-плечевой радикулоплексопатии. Обсуждаются клинические особенности данной формы по сравнению с диабетической пояснично-крестцовой радикулоплексопатией, инструментальная диагностика диабетических радикулоплексопатий, патогенетические механизмы заболевания, подходы к лечению. Показана эффективность препарата альфа-липоевой кислоты у пациентки с диабетической радикулоплексопатией.

диабетическая шейно-плечевая радикулоплексопатиядиабетическая пояснично-крестцовая радикулоплексопатияальфа-липоевая кислотаdiabetic cervicobrachial radiculoplexopathydiabetic lumbosacral radiculoplexopathyalpha-lipoic acidReferencesГлобальный доклад по диабету. Всемирная организация здравоохранения. 2018 https://apps.who.int/iris/handle/10665/275388Global report on diabetes. World health organisation. 2018]. https://apps.who.int/iris/handle/10665/275388International Diabetes Federation. IDF Diabetes Atlas – 8th edition: key messages. IDF https://diabetesatlas.org/key-messages.htmlInternational Diabetes Federation. IDF Diabetes Atlas – 8th edition: key messages. IDF https://diabetesatlas.org/key-messages.htmlPop-Busui R, Boulton AJ, Feldman EL, et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017 Jan;40(1):136-154. doi: 10.2337/dc16-2042.Pop-Busui R, Boulton AJ, Feldman EL, et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017 Jan;40(1):136-154. doi: 10.2337/dc16-2042.Dyck PJ. Radiculoplexus neuropathies: diabetic and nondiabetic varieties. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy. 4th ed. Vol. 2. Philadelphia: Elsevier Saunders; 2005. P. 1993-2037.Dyck PJ. Radiculoplexus neuropathies: diabetic and nondiabetic varieties. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy. 4th ed. Vol. 2. Philadelphia: Elsevier Saunders; 2005. P. 1993-2037.Llewelyn JG, Tomlinson D, Thomas PK. Diabetic neuropathies. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy. 4th ed. Vol. 2. Philadelphia: Elsevier Saunders; 2005. P.1951-91.Llewelyn JG, Tomlinson D, Thomas PK. Diabetic neuropathies. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy. 4th ed. Vol. 2. Philadelphia: Elsevier Saunders; 2005. P.1951-91.Горбачева ФЕ, Зиновьева ОЕ, Алексеева МЕ, Щекина РВ. Диабетическая амиотрофия: подходы к лечению. Неврологический журнал. 1997;(2):17-22.Gorbacheva FE, Zinov'eva OE, Alekseeva ME, Shchekina RV. Diabetic amyotrophy: treatment approaches. Nevrologicheskii zhurnal. 1997;(2):17-22. (InRuss.)Imtiaz KE, Lekwuwa G, Kaimal N, et al. Elevated cerebrospinal fluid protein in diabetic lumbosacral radiculoplexus neuropathy. QJM. 2012 Nov;105(11):1119-23. doi: 10.1093/qjmed/hcr166. Epub 2011 Sep 14.Imtiaz KE, Lekwuwa G, Kaimal N, et al. Elevated cerebrospinal fluid protein in diabetic lumbosacral radiculoplexus neuropathy. QJM. 2012 Nov;105(11):1119-23. doi: 10.1093/qjmed/hcr166. Epub 2011 Sep 14.Raff M, Asbury AK. Ischemic mononeuropathy and mononeuropathy multiplex in diabetes mellitus. N Engl J Med. 1968 Jul 4;279(1):17-21.Raff M, Asbury AK. Ischemic mononeuropathy and mononeuropathy multiplex in diabetes mellitus. N Engl J Med. 1968 Jul 4;279(1):17-21.Pascoe MK, Low PA, Windebank AJ, Litchy WJ. Subacute diabetic proximal neuropathy. Mayo Clin Proc. 1997 Dec;72(12): 1123-32.Pascoe MK, Low PA, Windebank AJ, Litchy WJ. Subacute diabetic proximal neuropathy. Mayo Clin Proc. 1997 Dec;72(12): 1123-32.Massie R, Mauermann ML, Staff NP, et al. Diabetic cervical radiculoplexus neuropathy: a distinct syndrome expanding the spectrum of diabetic radiculoplexus neuropathies. Brain. 2012 Oct;135(Pt 10):3074-88. doi: 10.1093/brain/aws244.Massie R, Mauermann ML, Staff NP, et al. Diabetic cervical radiculoplexus neuropathy: a distinct syndrome expanding the spectrum of diabetic radiculoplexus neuropathies. Brain. 2012 Oct;135(Pt 10):3074-88. doi: 10.1093/brain/aws244.Katz JS, Saperstein DS, Wolfe G, at al. Cervicobrachial involvement in diabetic radiculoplexopathy. Muscle Nerve. 2001 Jun;24(6): 794-8.Katz JS, Saperstein DS, Wolfe G, at al. Cervicobrachial involvement in diabetic radiculoplexopathy. Muscle Nerve. 2001 Jun;24(6): 794-8.Gupta G, Massie R, Doherty T, et al. Diabetic cranio-cervico-radiculoplexus neuropathy. PM R. 2015 Nov;7(11):1189-1193. doi: 10.1016/j.pmrj.2015.05.003. Epub 2015 May 12.Gupta G, Massie R, Doherty T, et al. Diabetic cranio-cervico-radiculoplexus neuropathy. PM R. 2015 Nov;7(11):1189-1193. doi: 10.1016/j.pmrj.2015.05.003. Epub 2015 May 12.Ахмеджанова ЛТ, Баринов АН, Строков ИА. Диабетические и недиабетические полиневропатии у пациентов с сахарным диабетом. Журнал неврологии и психиатрии им. С.С. Корсакова. 2018;118(4): 113-21.Akhmedzhanova LT, Barinov AN, Strokov IA. Diabetic and nondiabetic polyneuropathies in patients with diabetes mellitus. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2018;118(4):113-21. (In Russ.)Ng P, Dyck PJ, Laughlin R, et al. Lumbosacral radiculoplexus neuropathy. Incidence and the association with diabetes mellitus. Neurology. 2019 Mar 12;92(11):e1188-e1194. doi: 10.1212/WNL.0000000000007020. Epub 2019 Feb 13.Ng P, Dyck PJ, Laughlin R, et al. Lumbosacral radiculoplexus neuropathy. Incidence and the association with diabetes mellitus. Neurology. 2019 Mar 12;92(11):e1188-e1194. doi: 10.1212/WNL.0000000000007020. Epub 2019 Feb 13.Waldfogel JM, Nesbit SA, Dy SM, Sharma R. Pharmacotherapy for diabetic peripheral neuropathy pain and quality of life: A systematic review. Neurology. 2017 May 16;88(20):1958-1967. doi: 10.1212/WNL.0000000000003882. Epub 2017 Mar 24.Waldfogel JM, Nesbit SA, Dy SM, Sharma R. Pharmacotherapy for diabetic peripheral neuropathy pain and quality of life: A systematic review. Neurology. 2017 May 16;88(20):1958-1967. doi: 10.1212/WNL.0000000000003882. Epub 2017 Mar 24.Исайкин АИ, Кавелина ВА, Зиновьева ОЕ, Ахмеджанова ЛТ. Диабетическая проксимальная амиотрофия (клинический случай). Медицинский совет. 2014;(2):46-51.Isaikin AI, Kavelina VA, Zinov'eva OE, Akhmedzhanova LT. Diabetic proximal amyotrophy (clinical case). Meditsinskii sovet. 2014; (2):46-51. (InRuss.)Kilfoyle D, Kelkar P, Parry GJ. Pulsed methylprednisolone is a safe and effective treatment for diabetic amyotrophy. J Clin Neuromuscul Dis. 2003 Jun;4(4):168-70.Kilfoyle D, Kelkar P, Parry GJ. Pulsed methylprednisolone is a safe and effective treatment for diabetic amyotrophy. J Clin Neuromuscul Dis. 2003 Jun;4(4):168-70.Thaisetthawatkul P, Dyck PJ. Treatment of diabetic and nondiabetic lumbosacral radiculoplexus neuropathy. Curr Treat Options Neurol. 2010 Mar;12(2):95-9. doi: 10.1007/s11940-010-0059-8.Thaisetthawatkul P, Dyck PJ. Treatment of diabetic and nondiabetic lumbosacral radiculoplexus neuropathy. Curr Treat Options Neurol. 2010 Mar;12(2):95-9. doi: 10.1007/s11940-010-0059-8.Kawagashirea Y, Watanabe H, Oki Y, et al. Intravenous immunoglobulin therapy markedly ameliorates muscle weakness and severe pain in proximal diabetic neuropathy. J Neurol Neurosurg Psychiatry. 2007 Aug;78(8):899-901.Kawagashirea Y, Watanabe H, Oki Y, et al. Intravenous immunoglobulin therapy markedly ameliorates muscle weakness and severe pain in proximal diabetic neuropathy. J Neurol Neurosurg Psychiatry. 2007 Aug;78(8):899-901.Tamburin S, Zanette G. Intravenous immunoglobulin for the treatment of diabetic lumbosacral radiculoplexus neuropathy. Pain Med. 2009 Nov;10(8):1476-80. doi: 10.1111/j.1526-4637.2009.00704.x. Epub 2009 Sep 25.Tamburin S, Zanette G. Intravenous immunoglobulin for the treatment of diabetic lumbosacral radiculoplexus neuropathy. Pain Med. 2009 Nov;10(8):1476-80. doi: 10.1111/j.1526-4637.2009.00704.x. Epub 2009 Sep 25.Chan YC, Lo YL, Chan ES. Immunotherapy for diabetic amyotrophy. Cochrane Database Syst Rev. 2012 Jun 13; (6):CD006521. doi: 10.1002/14651858.CD006521.pub3.Chan YC, Lo YL, Chan ES. Immunotherapy for diabetic amyotrophy. Cochrane Database Syst Rev. 2012 Jun 13; (6):CD006521. doi: 10.1002/14651858.CD006521.pub3.Ametov AS, Barinov A, Dyck PJ, et al. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. Diabetes Care. 2003 Mar; 26(3):770-6.Ametov AS, Barinov A, Dyck PJ, et al. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. Diabetes Care. 2003 Mar; 26(3):770-6.Ziegler D, Hanefeld M, Ruhnau KJ, et al. Treatment of symptomatic diabetic peripheral neuropathy with the antioxydant alpha-lypoic acid. (ALADIN study group). Diabetologia. 1995 Dec;38(12):1425-33.Ziegler D, Hanefeld M, Ruhnau KJ, et al. Treatment of symptomatic diabetic peripheral neuropathy with the antioxydant alpha-lypoic acid. (ALADIN study group). Diabetologia. 1995 Dec;38(12):1425-33.Ziegler D, Nowak H, Kempler P, et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med. 2004 Feb;21(2): 114-21.Ziegler D, Nowak H, Kempler P, et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med. 2004 Feb;21(2): 114-21.Строков ИА, Ахмеджанова ЛТ, Баринов АН и др. Патогенетическая терапия диабетической полиневропатии альфа-липоевой кислотой с точки зрения доказательной медицины. Эффективная фармакотерапия. 2019;(1):32-40.Strokov IA, Akhmedzhanova LT, Barinov AN, et al. Pathogenetic therapy of diabetic polyneuropathy with alpha-lipoic acid from the point of view of evidence-based medicine. Effektivnaya farmakoterapiya. 2019;(1): 32-40. (InRuss.)Tesfaye S. Boulton AJM, Dyck PJ, et al. Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments. Diabetes Care. 2010 Oct;33(10): 2285-93. doi: 10.2337/dc10-1303.Tesfaye S. Boulton AJM, Dyck PJ, et al. Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments. Diabetes Care. 2010 Oct;33(10): 2285-93. doi: 10.2337/dc10-1303.Reljanovic M, Reichel G, Rett K, et al. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized doubleblind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy. Free Radic Res. 1999 Sep;31(3):171-9.Reljanovic M, Reichel G, Rett K, et al. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized doubleblind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy. Free Radic Res. 1999 Sep;31(3):171-9.Ziegler D, Low PA, Boulton AJM, et al. Efficacy and safety of antioxidant treatment with alpha-lipoic acid over 4 years in diabetic polyneuropathy:the NATHAN-1 trial. Diabetes Care. 2011 Sep;34(9):2054-60. doi: 10.2337/dc11-0503. Epub 2011 Jul 20.Ziegler D, Low PA, Boulton AJM, et al. Efficacy and safety of antioxidant treatment with alpha-lipoic acid over 4 years in diabetic polyneuropathy:the NATHAN-1 trial. Diabetes Care. 2011 Sep;34(9):2054-60. doi: 10.2337/dc11-0503. Epub 2011 Jul 20.

The authors declare that there are no conflicts of interest present.